Ranbaxy Laboratories, Dr Reddy's, Nicholas Piramal and three other Indian drug...

The auto maker is on a rough road with demand for both CVs and cars sluggish. With...

The credit growth in the current financial year has slowed down to 22.6 per cent at...

Leading Indian pharmaceutical companies, which are largely focused on the global...

Pharma firms have slowed down on R&D activities in a bid to control costs.

The FIIs' stake in Reliance Industries has increased from 20.22 per cent at the end of...

Birla patriarch, B K Birla's decision to give Kesoram Industries to his grandson...

Acquisition will ensure iron reserves for Vedanta.

Foreign institutional investors have shown signs of reducing their exposure to the oil...

India's leading corporate houses like Mahindra & Mahindra, Hindustan Construction...

After raising its stake to 100% in UK JV; the firm plans to expand European portfolio...

German retail giant Metro Cash & Carry and India's emerging retail venture Reliance...

The proposal will help India, one of the most cost-effective location for...

The global consultancy firm PricewaterhouseCoopers is foraying into custom-made...

China drug firms plan JVs in India

Companies seeking to tie up with nationwide pharmacy chain.

The group is planning to make a foray in this hitherto unorganised sector by...

Elder Pharmaceuticals, one of the fast growing pharmaceutical formulation company, is...

Stem cell research major GlobalStem in talks for a strategic alliance.

The Rs 900-crore (Rs 9 billion) Alkem Laboratories and the leading US pharmaceutical...